The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans
In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read MoreTop Stories
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Filter
Improving Health Outcomes by Empowering Patients: The Future Is Here
Empowering patients and involving them as key stakeholders in the drug development lifecycle can help...
The Quest for Omnichannel: Is Medical Affairs Ready?
Commercial and Medical Affairs must partner with each other to achieve the real benefits of...
Person-First Language (PFL) in Medical Communications: Usage and Awareness
The use of patient-first language (PFL) is an important feature of a patient-centered care model...
How Patient Influencers Can Amplify the Pharma Voice
Learn more about patient influencers and their reach and relevance and how you can apply...
Why Is It Important to Include Patients as Peer Reviewers
Patient peer reviews offer an amazing opportunity to see how HCPs and pharmaceutical companies are...
New Open Data Sharing Policies: WHO and NIH Take Big Steps to Improve Public Health
Making research and data reproducible is vital to improving public health and reinstating trust in...